198 results on '"Whittington, Melanie D."'
Search Results
2. Living Health Technology Assessment: Issues, Challenges and Opportunities
3. The Influence of the Rural Transitions Nurse Program for Veterans on Healthcare Utilization Costs
4. Effect of State Immunization Information System Based Reminder/Recall for Influenza Vaccinations: A Randomized Trial of Autodialer, Text, and Mailed Messages
5. Effect of State Immunization Information System Centralized Reminder and Recall on HPV Vaccination Rates
6. The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19
7. Development and Scoring of a Survey on Public Health Accreditation Capacity
8. Economic and clinical burden of comorbidities among patients with acromegaly
9. Does Cost-Effectiveness Analysis Overvalue Potential Cures? Exploring Alternative Methods for Applying a “Shared Savings” Approach to Cost Offsets
10. Health costs of women with chronic overlapping pain conditions by opioid and complementary and integrative health use
11. Performing Cost-Effectiveness Analyses to Support Policy Making: Key Lessons From the Assessment of Aducanumab
12. Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease
13. Cost-Effectiveness of Three Doses of a Behavioral Intervention to Prevent or Delay Type 2 Diabetes in Rural Areas
14. Effect of State Immunization Information System Based Reminder/Recall for Influenza Vaccinations: A Randomized Trial of Autodialer, Text, and Mailed Messages
15. A Systems-Based Morbidity and Mortality Conference Was Associated With a Transient Reduction in ECG Completion Times
16. Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States
17. The effectiveness and value of lecanemab for early Alzheimer disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum
18. Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and value
19. Cost-effectiveness of Lifestyle Africa: an adaptation of the diabetes prevention programme for delivery by community health workers in urban South Africa
20. Abstract 13412: Electronic Consultation for the Management of Atrial Fibrillation is Associated With Higher Healthcare Costs
21. Screening test recommendations for methicillin-resistant Staphylococcus aureus surveillance practices: A cost-minimization analysis
22. Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis
23. Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations
24. Differences in cardiac testing resource utilization using two different risk stratification schemes
25. Oral treatments for outpatient COVID-19: Effectiveness and value
26. Comment on “Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States”
27. Value of Public Health Funding in Preventing Hospital Bloodstream Infections in the United States
28. The effectiveness and value of aducanumab for Alzheimer’s disease
29. The influence of a Sprint optimization and training intervention on time spent in the electronic health record (EHR)
30. Patient and Payer Preferences for Additional Value Criteria
31. The effectiveness and value of digital health technologies as an adjunct to medication-assisted therapy for opioid use disorder
32. The Referral Coordination Team: A Redesign of Specialty Care to Enhance Service Delivery and Value in Sleep Medicine
33. Reduced admission rates and resource utilization for chest pain patients using an electronic health record‐embedded clinical pathway in the emergency department
34. Perspectives of VA Primary Care Clinicians Toward Electronic Consultation-Related Workload Burden
35. A Systems-Based Morbidity and Mortality Conference Was Associated With a Transient Reduction in ECG Completion Times.
36. MON-306 Acromegaly Comorbidity Costs, Quality of Life, and Mortality: Lifetime Comparisons for Controlled Acromegaly, Uncontrolled Acromegaly, and the General US Population
37. Valuing Chimeric Antigen Receptor T-Cell Therapy: Current Evidence, Uncertainties, and Payment Implications
38. Development and Scoring of a Survey on Public Health Accreditation Capacity
39. Supplemental Material, supplementary_material_FINAL - Development and Scoring of a Survey on Public Health Accreditation Capacity
40. Technical_Appendix – Supplemental material for Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 and Type 2 Diabetes in England
41. Paying for CAR-T Therapy Amidst Limited Health System Resources
42. Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell Lymphoma
43. Recommendations for the Use of Audit and Feedback to De-Implement Low-Value Care
44. Assessing the Value of Sarilumab Monotherapy for Adults with Moderately to Severely Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis
45. Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy
46. Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia
47. UK survey of non-medical use of prescription drugs (NMURx) as a valuable source of general population illicit drug use data
48. Cost Savings Associated With Electronic Specialty Consultations.
49. RCT of Centralized Vaccine Reminder/Recall for Adults
50. Prices For Common Cardiovascular Drugs In The US Are Not Consistently Aligned With Value
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.